Subsequent Entry Biologic Litigation Set to Take Off in Canada
The Canadian pharmaceutical industry is entering a new era as Subsequent Entry Biologic (SEB) litigation begins to emerge in the Canadian pharmaceutical landscape. Biologic drugs
November 22, 2012
1 Comment